LSB LakeShore Biopharma: Company Value to Revenue Ratio

Public company logo of LakeShore Biopharma (LSB)

LakeShore Biopharma Co. (LSB) growth is based on the Chinese rabies vaccine market and R&D development. This EV/Sales chart illustrates the business value to revenue dynamics excluding debt, where the indicator reaches . However, corporate disputes and pricing pressure are eroding margins. High barriers to entry are ensured by strict GMP standards, patents, and lengthy clinical trials.

LSB YS Biopharma Co., Ltd.: Enterprise Value-to-Revenue Ratio in the range 07/04/2022 - 11/20/2026

LSB (LakeShore Biopharma Co., Ltd.): analytical breakdowns and indicator data

- price and consensus price forecast:
- company stock capitalization data:
Fundamental company valuation:LSB, ysbiopharm.com
Mass-produced product of LakeShore Biopharma

To filter out the risks of overpaying for an asset, it is necessary to analyze the ratio of Enterprise Value (EV) to annual sales. By tracking changes in the EV/Sales metric, an investor assesses the market value of the company, accounting for net debt relative to its revenue, which is critical during the expansion of the PIKA platform and the capture of Asian vaccine markets by LakeShore Biopharma Co. (LSB).